Obesity and CKD: How to Assess the Risk?

American Journal of Kidney Diseases

Volumn 52, Issue 1, 2008, Pages 1-6

  Ritz, Eberhard ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CREATININE; EPLERENONE; POLYUNSATURATED FATTY ACID; REACTIVE OXYGEN METABOLITE; TEMPOL;

ADRENAL GLAND; ALDOSTERONE BLOOD LEVEL; ASIA; ASIAN; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDITORIAL; EXTRACELLULAR FLUID; EXTRACELLULAR SPACE; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INTRAABDOMINAL FAT; JAPANESE; KIDNEY BIOPSY; OBESITY; PHARMACOLOGICAL BLOCKING; PREVENTIVE MEDICINE; PROTEINURIA; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; COMORBIDITY; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY; OBESITY, MORBID; PROGNOSIS; PROTEINURIA; RISK ASSESSMENT; SEX DISTRIBUTION; SURVIVAL ANALYSIS;

EID: 45449117480     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.05.002     Document Type: Editorial

References (49)

1. Praga M. Obesity-a neglected culprit in renal disease. Nephrol Dial Transplant 17 (2002) 1157-1159
2. Bonnet F., Deprele C., Sassolas A., et al. Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37 (2001) 720-727
3. Morales E., Valero M.A., Leon M., et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41 (2003) 319-327
4. Bello A.K., de Zeeuw D., El Nahas M., et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 22 (2007) 1619-1627
5. Chagnac A.W.T., Korzets A., Ramadan E., Hirsch J., and Gafter U. Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 278 (2000) F817-F822
6. Weisinger J.R., Kempson R.L., Eldridge F.L., and Swenson R.S. The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 81 (1974) 440-447
7. Kambham N., Markowitz G.S., Valeri A.M., et al. Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59 (2001) 1498-1509
8. Iseki K., Ikemiya Y., Kinjo K., et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 65 (2004) 1870-1876
9. Hsu C.Y., McCulloch C.E., Iribarren C., et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
10. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363 (2004) 157-163
11. Ejerblad E., Fored C.M., Lindblad P., et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 17 (2006) 1695-1702
12. Brenner B.M., Garcia D.L., and Anderson S. Glomeruli and blood pressure. Less of one, more the other?. Am J Hypertens 1 (1988) 335-347
13. Barker D.J., Osmond C., Forsen T.J., et al. Trajectories of growth among children who have coronary events as adults. N Engl J Med 353 (2005) 1802-1809
14. Foster M.C., Hwang S.-J., Larson M.G., et al. Overweight, obesity, and the development of stage 3 CKD: The Framingham Heart Study. Am J Kidney Dis 52 (2008) 39-48
15. Poggio E.D., and Rule A.D. Can we do better than a single estimated GFR threshold when screening for chronic kidney disease?. Kidney Int 72 (2007) 534-536
16. Calabro P., and Yeh E.T. Intra-abdominal adiposity, inflammation, and cardiovascular risk: new insight into global cardiometabolic risk. Curr Hypertens Rep 10 (2008) 32-38
17. Ritz E. Metabolic syndrome and kidney disease. Blood Purif 26 (2008) 59-62
18. Klein S., Fontana L., Young V.L., Coggan A.R., et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med 350 (2004) 2549-2557
19. Elsayed E.F., Sarnak M.J., Tighiouart H., et al. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52 (2008) 29-38
20. Smith H.W. The Kidney-Structure and Function in Health and Disease (1964), Oxford University Press, Oxford, UK 543
21. Bosma R.J., van der Heide J.J., Oosterop E.J., et al. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 65 (2004) 259-265
22. Tomaszewski M., Charchar F.J., Maric C., et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 71 (2007) 816-821
23. Krikken J.A., Lely A.T., Bakker S.J., and Navis G. The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int 71 (2007) 260-265
24. Schoner W., and Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293 (2007) C509-C536
25. Hall J.E. The kidney, hypertension, and obesity. Hypertension 41 (2003) 625-633
26. Dengel D.R., Goldberg A.P., Mayuga R.S., et al. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 28 (1996) 127-132
27. Hall J.E., Brands M.W., Mizelle H.L., et al. Chronic intrarenal hyperinsulinemia does not cause hypertension. Am J Physiol 260 (1991) F663-F669
28. D'Agati V.D., and Markowitz G.S. Supersized kidneys: Lessons from the preclinical obese kidney. Kidney Int 73 (2008) 909-910
29. Remuzzi G., and Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339 (1998) 1448-1456
30. Keith D.S., Nichols G.A., Gullion C.M., et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
31. Lastra G., Manrique C., and Sowers J.R. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 13 (2006) 365-373
32. Serra A., Romero R., Lopez D., Navarro M., et al. Renal injury in the extremely obese patients with normal renal function. Kidney Int 73 (2008) 947-955
33. Pinto-Sietsma S.J., Navis G., Janssen W.M., et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41 (2003) 733-741
34. Romero-Corral A., Lopez-Jimenez F., Boarin S., Sierra-Johnson J., and Somers V.K. Normal weight obesity: A risk factor for cardiometabolic dysregulations. J Am Coll Cardiol 51 suppl 1 (2008) A350 abstr 814-4
35. Bonnet F., Marre M., Halimi J.M., et al. Waist circumference and the metabolic syndrome predict the development of elevated albuminuria in non-diabetic subjects: the DESIR Study. J Hypertens 24 (2006) 1157-1163
36. de Boer I.H., and Steffes M.W. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes. J Am Soc Nephrol 18 (2007) 1036-1037
37. Goodfriend T.L., Ball D.L., Egan B.M., Campbell W.B., and Nithipatikom K. Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 43 (2004) 358-374
38. Nagase M., Yoshida S., Shibata S., et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 17 (2006) 3438-3446
39. Nagase M., Shibata S., Yoshida S., et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 47 (2006) 1084-1093
40. Shibata S., Nagase M., Yoshida S., et al. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49 (2007) 355-364
41. Bakker S.J., Gansevoort R.T., and de Zeeuw D. Metabolic syndrome: a fata morgana?. Nephrol Dial Transplant 22 (2007) 15-20
42. Nagai Y., Yao L., Kobori H., et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol 16 (2005) 574-575
43. Mykkanen L., Zaccaro D.J., Wagenknecht L.E., et al. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 47 (1998) 793-800
44. Brantsma A.H., Bakker S.J., Hillege H.L., et al. Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction of type 2 diabetes. Diabetes Care 28 (2005) 2525-2530
45. Caramori ML, Hansen BC, Mauer M, et al: Renal structural-functional relationships in spontaneously obese rhesus monkeys (RhM). Renal Week 2007: American Society of Nephrology Annual Meeting, San Francisco, CA, October 31 to November 5, 2007 (abstr F-PO331)
46. Sanches F.M.R., Avesani C.M., Kamimura M.A., et al. Waist circumference and visceral fat in CKD: A cross-sectional study. Am J Kidney Dis 52 (2008) 66-73
47. Odamaki M., Furuya R., Ohkawa S., et al. Altered abdominal fat distribution and its association with the serum lipid profile in non-diabetic haemodialysis patients. Nephrol Dial Transplant 14 (1999) 2427-2432
48. Yamauchi T., Kuno T., Takada H., et al. The impact of visceral fat on multiple risk factors and carotid atherosclerosis in chronic haemodialysis patients. Nephrol Dial Transplant 18 (2003) 1842-1847
49. Chen H.-M., Li S.-J., Chen H.-P., Wang Q.-W., Li L.-S., and Liu Z.-H. Obesity-related glomerulopathy in China: A case series of 90 patients. Am J Kidney Dis 52 (2008) 58-65